{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:03:24Z","timestamp":1789689804286,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ERA-Net CHIST-ERA","award":["93603"],"award-info":[{"award-number":["93603"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57812-8","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:06:35Z","timestamp":1782320795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal PET\/CT-based PD-L1 status prediction in lung cancer via semi-supervised and unsupervised deep learning"],"prefix":"10.1038","volume":"16","author":[{"given":"Ronrick","family":"Da-Ano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Tankyevych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Duysinx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lallemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hustinx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lovinfosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Cheze","family":"Le Rest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Visvikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"57812_CR1","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck, M. et al. Pembrolizumab versus chemotherapy for pd-l1-positive non-small-cell lung cancer. N. Engl. J. Med. 375, 1823\u201333 (2016).","journal-title":"N. Engl. J. Med."},{"key":"57812_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lungcan.2017.08.005","volume":"112","author":"R Brody","year":"2017","unstructured":"Brody, R. et al. Pd-l1 expression in advanced nsclc: Insights into risk stratification and treatment selection from a systematic literature review. Lung Cancer 112, 200\u201315 (2017).","journal-title":"Lung Cancer"},{"key":"57812_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3904\/kjim.2020.178","volume":"36","author":"CH Nam","year":"2021","unstructured":"Nam, C. H. et al. Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer. Korean J. Intern. Med. 36, 975 (2021).","journal-title":"Korean J. Intern. Med."},{"key":"57812_CR4","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3390\/ijms20102578","volume":"20","author":"T Takahashi","year":"2019","unstructured":"Takahashi, T., Tateishi, A., Bychkov, A. & Fukuoka, J. Remarkable alteration of pd-l1 expression after immune checkpoint therapy in patients with non-small-cell lung cancer: two autopsy case reports. Int. J. Mol. Sci. 20, 2578 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"57812_CR5","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","volume":"378","author":"M Socinski","year":"2018","unstructured":"Socinski, M. et al. Atezolizumab for first-line treatment of metastatic nonsquamous nsclc. N. Engl. J. Med. 378, 2288\u2013301 (2018).","journal-title":"N. Engl. J. Med."},{"key":"57812_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jtho.2016.04.014","volume":"11","author":"H Yu","year":"2016","unstructured":"Yu, H., Boyle, T. A., Zhou, C., Rimm, D. L. & Hirsch, F. R. PD-L1 expression in lung cancer. J. Thorac. Oncol. 11, 964\u2013975 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"57812_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/ijms17050790","volume":"17","author":"G Scognamiglio","year":"2016","unstructured":"Scognamiglio, G. et al. Variability in immunohistochemical detection of programmed death ligand 1 (pd-l1) in cancer tissue types. Int. J. Mol. Sci. 17, 790 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"57812_CR8","doi-asserted-by":"publisher","first-page":"e1213934","DOI":"10.1080\/2162402X.2016.1213934","volume":"5","author":"D Pinato","year":"2016","unstructured":"Pinato, D. et al. Intra-tumoral heterogeneity in the expression of programmed-death (pd) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy. Oncoimmunology. 5, e1213934 (2016).","journal-title":"Oncoimmunology."},{"key":"57812_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14737159.2017.1398083","volume":"17","author":"P Hofman","year":"2017","unstructured":"Hofman, P. Pd-l1 immunohistochemistry for non-small cell lung carcinoma: Which strategy should be adopted? Expert Rev. Mol. Diagn. 17, 1097\u2013108 (2017).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"57812_CR10","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1007\/s00259-017-3802-5","volume":"44","author":"S Rossi","year":"2017","unstructured":"Rossi, S. et al. Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors. Eur. J. Nucl. Med. Mol. Imaging 44, 2310\u20132325 (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR11","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","volume":"393","author":"T Mok","year":"2019","unstructured":"Mok, T. et al. Pembrolizumab versus chemotherapy for previously untreated, pd-l1-expressing, locally advanced or metastatic non-small-cell lung cancer (keynote-042): A randomised, open-label, controlled, phase 3 trial. Lancet (London England) 393, 1819\u201330 (2019).","journal-title":"Lancet (London England)"},{"key":"57812_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48, 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"key":"57812_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00426-y","volume":"7","author":"M Sollini","year":"2017","unstructured":"Sollini, M., Cozzi, L., Antunovic, L., Chiti, A. & Kirienko, M. Pet radiomics in NSCLC: State of the art and a proposal for harmonization of methodology. Sci. Rep. 7, 1\u201315 (2017).","journal-title":"Sci. Rep."},{"key":"57812_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00259-016-3325-5","volume":"43","author":"M-C Desseroit","year":"2016","unstructured":"Desseroit, M.-C. et al. Development of a nomogram combining clinical staging with 18 F-FDG PET\/CT image features in non-small-cell lung cancer stage i\u2013iii. Eur. J. Nucl. Med. Mol. Imaging 43, 1477\u20131485 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cac2.12023","volume":"40","author":"W Tan","year":"2020","unstructured":"Tan, W. et al. Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun. (Lond. Engl.) 40, 135\u201353 (2020).","journal-title":"Cancer Commun. (Lond. Engl.)"},{"key":"57812_CR16","doi-asserted-by":"publisher","first-page":"106626","DOI":"10.1016\/j.compeleceng.2020.106626","volume":"84","author":"G Savitha","year":"2020","unstructured":"Savitha, G. & Jidesh, P. A holistic deep learning approach for identification and classification of sub-solid lung nodules in computed tomographic scans. Comput. Electr. Eng. 84, 106626 (2020).","journal-title":"Comput. Electr. Eng."},{"key":"57812_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun, R. et al. A radiomics approach to assess tumour-infiltrating cd8 cells and response to anti-pd-1 or anti-pd-l1 immunotherapy: An imaging biomarker, retrospective multicohort study. Lancet Oncol. 19, 1180\u20131191 (2018).","journal-title":"Lancet Oncol."},{"key":"57812_CR18","doi-asserted-by":"crossref","unstructured":"Manafi-Farid, R. et al. [18F] FDG-PET\/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications. In Seminars in Nuclear Medicine (2022).","DOI":"10.1053\/j.semnuclmed.2022.04.004"},{"key":"57812_CR19","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20135 (2018).","journal-title":"Science"},{"key":"57812_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00259-022-06001-6","volume":"50","author":"M Hatt","year":"2023","unstructured":"Hatt, M. et al. Joint EANM\/SNMMI guideline on radiomics in nuclear medicine: Jointly supported by the EANM physics committee and the SNMMI physics, instrumentation and data sciences council. Eur. J. Nucl. Med. Mol. Imaging 50, 352\u2013375 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00330-021-08104-4","volume":"32","author":"B Badic","year":"2022","unstructured":"Badic, B. et al. Prediction of recurrence after surgery in colorectal cancer patients using radiomics from diagnostic contrast-enhanced computed tomography: A two-center study. Eur. Radiol. 32, 405\u2013414 (2022).","journal-title":"Eur. Radiol."},{"key":"57812_CR22","doi-asserted-by":"crossref","unstructured":"Chen, X. et al. Recent advances and clinical applications of deep learning in medical image analysis. Medical Image Anal. 102444 (2022).","DOI":"10.1016\/j.media.2022.102444"},{"key":"57812_CR23","unstructured":"Tan, M. & Le, Q. EfficientNet: Rethinking model scaling for convolutional neural networks. In International Conference on Machine Learning 6105\u20136114 (2019)."},{"key":"57812_CR24","doi-asserted-by":"crossref","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. Deep residual learning for image recognition. In IEEE Conference on Computer Vision and Pattern Recognition 770\u2013778 (2016).","DOI":"10.1109\/CVPR.2016.90"},{"key":"57812_CR25","doi-asserted-by":"publisher","first-page":"102109","DOI":"10.1016\/j.artmed.2021.102109","volume":"117","author":"P-H Conze","year":"2021","unstructured":"Conze, P.-H. et al. Abdominal multi-organ segmentation with cascaded convolutional and adversarial deep networks. Artif. Intell. Med. 117, 102109 (2021).","journal-title":"Artif. Intell. Med."},{"key":"57812_CR26","doi-asserted-by":"crossref","unstructured":"Wang, C. Non-invasive measurement using deep learning algorithm based on multi-source features fusion to predict PD-L1 expression and survival in NSCLC. Front. Immunol. 13, (2022).","DOI":"10.3389\/fimmu.2022.828560"},{"key":"57812_CR27","first-page":"297","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Predicting EGFR and PD-L1 status in NSCLC patients using multitask AI system based on CT images. Front. Immunol. 13, 297 (2022).","journal-title":"Front. Immunol."},{"key":"57812_CR28","doi-asserted-by":"crossref","unstructured":"Wang, C. Deep learning to predict EGFR mutation and PD-L1 expression status in non-small-cell lung cancer on computed tomography images. J. Oncol. 2021 (2021).","DOI":"10.1155\/2021\/5499385"},{"key":"57812_CR29","doi-asserted-by":"crossref","unstructured":"Zhu, Y. A CT-derived deep neural network predicts for programmed death ligand-1 expression status in advanced lung adenocarcinomas. Ann. Transl. Med. 8, (2020).","DOI":"10.21037\/atm-19-4690"},{"key":"57812_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00259-020-04771-5","volume":"48","author":"Y Han","year":"2021","unstructured":"Han, Y. et al. Histologic subtype classification of non-small cell lung cancer using PET\/CT images. Eur. J. Nucl. Med. Mol. Imaging 48, 350\u2013360 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR31","doi-asserted-by":"publisher","first-page":"16720","DOI":"10.1038\/s41598-024-66487-y","volume":"14","author":"R Da-ano","year":"2024","unstructured":"Da-ano, R. et al. Automated PD-L1 status prediction in lung cancer with multi-modal PET\/CT fusion. Sci. Rep. 14, 16720. https:\/\/doi.org\/10.1038\/s41598-024-66487-y (2024).","journal-title":"Sci. Rep."},{"issue":"9","key":"57812_CR32","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"W Travis","year":"2015","unstructured":"Travis, W. et al. The 2015 world health organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10(9), 1243\u20131260 (2015).","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"57812_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","volume":"151","author":"F Detterbeck","year":"2017","unstructured":"Detterbeck, F. The eighth edition lung cancer stage classification. Chest 151(1), 193\u2013203 (2017).","journal-title":"Chest"},{"key":"57812_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1109\/TMI.2008.2012036","volume":"28","author":"M Hatt","year":"2009","unstructured":"Hatt, M. et al. A fuzzy locally adaptive bayesian segmentation approach for volume determination in pet. IEEE Trans. Med. Imaging 28, 881\u2013893 (2009).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"57812_CR35","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1038\/s41598-020-66110-w","volume":"10","author":"R Da-ano","year":"2020","unstructured":"Da-ano, R. et al. Performance comparison of modified combat for harmonization of radiomic features for multicenter studies. Sci. Rep. 10, 10248 (2020).","journal-title":"Sci. Rep."},{"issue":"9","key":"57812_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3d slicer as an image computing platform for the quantitative imaging network. Magn. Reson. Imaging 30(9), 1323\u201341 (2012).","journal-title":"Magn. Reson. Imaging"},{"key":"57812_CR37","doi-asserted-by":"crossref","unstructured":"Belli, M., Mori, M., Broggi, S. et al. Quantifying the robustness of [18f]fdg-pet\/ct radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Phys. Med. 105\u201311 (2018).","DOI":"10.1016\/j.ejmp.2018.05.013"},{"key":"57812_CR38","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1038\/srep03529","volume":"3","author":"E Velazquez","year":"2013","unstructured":"Velazquez, E. et al. Volumetric ct-based segmentation of nsclc using 3d-slicer. Sci. Rep. 3, 3529 (2013).","journal-title":"Sci. Rep."},{"key":"57812_CR39","first-page":"6256","volume":"33","author":"Q Xie","year":"2020","unstructured":"Xie, Q. et al. Unsupervised data augmentation for consistency training. Adv. Neural Inf. Process. 33, 6256\u20136268 (2020).","journal-title":"Adv. Neural Inf. Process."},{"key":"57812_CR40","unstructured":"DeVries, T. et al. Improved regularization of convolutional neural networks with cutout. arXiv arXiv:1708.04552 (2017)."},{"key":"57812_CR41","doi-asserted-by":"crossref","unstructured":"Cubuk, E. Randaugment: Practical automated data augmentation with a reduced search space. In Proceedings of the IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 702\u2013703 (2020).","DOI":"10.1109\/CVPRW50498.2020.00359"},{"key":"57812_CR42","unstructured":"Witten, I., Frank, E., Hall, I. et al. Datamining: Practical machine learning tools and techniques. In Morgan Kaufmann (2016)."},{"key":"57812_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.media.2019.03.009","volume":"54","author":"V Cheplygina","year":"2019","unstructured":"Cheplygina, V., de Bruijne, M. & Pluim, J. P. Not-so-supervised: A survey of semi-supervised, multi-instance, and transfer learning in medical image analysis. Med. Image Anal. 54, 280\u2013296. https:\/\/doi.org\/10.1016\/j.media.2019.03.009 (2019).","journal-title":"Med. Image Anal."},{"key":"57812_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00259-018-4182-6","volume":"46","author":"EY Hwang","year":"2019","unstructured":"Hwang, E. Y. et al. Association between 18f-fdg pet metabolic parameters and pd-l1 expression in non-small cell lung cancer. Eur. J. Nucl. Med. Mol. Imaging 46, 123\u2013131. https:\/\/doi.org\/10.1007\/s00259-018-4182-6 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR45","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2967\/jnumed.119.236117","volume":"61","author":"X Mu","year":"2020","unstructured":"Mu, X. et al. Total lesion glycolysis on 18f-fdg pet\/ct correlates with pd-l1 expression in non-small cell lung cancer. J. Nucl. Med. 61, 1230\u20131236. https:\/\/doi.org\/10.2967\/jnumed.119.236117 (2020).","journal-title":"J. Nucl. Med."},{"key":"57812_CR46","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1007\/s00259-021-05349-2","volume":"48","author":"X Mu","year":"2021","unstructured":"Mu, X. et al. 18f-fdg pet\/ct metabolic parameters and pd-l1 expression in nsclc: A systematic review and meta-analysis. Eur. J. Nucl. Med. Mol. Imaging 48, 3890\u20133902. https:\/\/doi.org\/10.1007\/s00259-021-05349-2 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2019.04.001","volume":"132","author":"S Takamori","year":"2019","unstructured":"Takamori, S. et al. Suvmax on fdg pet\/ct is associated with pd-l1 expression in nsclc. Lung Cancer 132, 1\u20137. https:\/\/doi.org\/10.1016\/j.lungcan.2019.04.001 (2019).","journal-title":"Lung Cancer"},{"key":"57812_CR48","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00259-018-4055-x","volume":"45","author":"M Kirienko","year":"2018","unstructured":"Kirienko, M. et al. Fdg pet\/ct and pd-l1 expression in lung cancer: Influence of histology and tumor heterogeneity. Eur. J. Nucl. Med. Mol. Imaging 45, 2091\u20132101. https:\/\/doi.org\/10.1007\/s00259-018-4055-x (2018).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"57812_CR49","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jtho.2020.04.012","volume":"15","author":"F Mueller","year":"2020","unstructured":"Mueller, F. et al. Lack of consistent association between fdg uptake and pd-l1 expression in nsclc. J. Thorac. Oncol. 15, 1234\u20131243. https:\/\/doi.org\/10.1016\/j.jtho.2020.04.012 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"57812_CR50","doi-asserted-by":"publisher","first-page":"330","DOI":"10.21037\/tlcr-20-789","volume":"10","author":"N Prinzi","year":"2021","unstructured":"Prinzi, N. et al. Challenges in pd-l1 immunohistochemistry assessment in nsclc. Transl. Lung Cancer Res. 10, 330\u2013345. https:\/\/doi.org\/10.21037\/tlcr-20-789 (2021).","journal-title":"Transl. Lung Cancer Res."},{"key":"57812_CR51","doi-asserted-by":"publisher","first-page":"109258","DOI":"10.1016\/j.ejrad.2020.109258","volume":"131","author":"B Badi\u0107","year":"2020","unstructured":"Badi\u0107, B. et al. Radiomics variability and standardization challenges in pet imaging. Eur. J. Radiol. 131, 109258. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109258 (2020).","journal-title":"Eur. J. Radiol."},{"key":"57812_CR52","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamaoncol.2017.0013","volume":"3","author":"DL Rimm","year":"2017","unstructured":"Rimm, D. L. et al. Reproducibility of pd-l1 immunohistochemistry assays in nsclc. JAMA Oncol. 3, 1051\u20131058. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0013 (2017).","journal-title":"JAMA Oncol."},{"key":"57812_CR53","unstructured":"Xie, Q., Dai, Z., Hovy, E., Luong, M.-T. & Le, Q.\u00a0V. Unsupervised data augmentation for consistency training. arXiv preprint arXiv:1904.12848 (2020)."},{"key":"57812_CR54","unstructured":"Sohn, K. et al. Fixmatch: Simplifying semi-supervised learning with consistency and confidence. arXiv preprint arXiv:2001.07685 (2020)."},{"key":"57812_CR55","doi-asserted-by":"publisher","first-page":"9912","DOI":"10.48550\/arXiv.2006.09882","volume":"33","author":"M Caron","year":"2020","unstructured":"Caron, M. et al. Unsupervised learning of visual features by contrasting cluster assignments. Adv. Neural Inf. Process. Syst. 33, 9912\u20139924. https:\/\/doi.org\/10.48550\/arXiv.2006.09882 (2020).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"57812_CR56","doi-asserted-by":"publisher","unstructured":"Azizi, S. et al. Big self-supervised models advance medical image classification. In Proceedings of the IEEE\/CVF International Conference on Computer Vision 3478\u20133488 https:\/\/doi.org\/10.48550\/arXiv.2101.05224 (2021).","DOI":"10.48550\/arXiv.2101.05224"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57812-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:08:07Z","timestamp":1789686487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57812-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57812"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57812-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee of the University of Poitiers, France. Informed consents were obtained for all patients. All procedures were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29100"}}